TRIPS and the Pharmaceutical Industry in Bangladesh: Towards a National Strategy
The paper presents a study of the WTO-Doha Declaration on TRIPS and Public Health and explores the opportunities of the growth of Bangladesh’s domestic pharmaceutical industry. The paper comes up with a number of policy suggestions in terms of designing a national strategy for the development of Bangladesh’s pharmaceutical sector in the context of the Doha Declaration.
|Date of creation:||Apr 2003|
|Date of revision:|
|Contact details of provider:|| Postal: House 40C, Road 32, Dhanmondi R/A, Dhaka 1000|
Phone: (880-2) 8124770
Fax: (880-2) 8130951
Web page: http://www.cpd.org.bd
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:pdb:opaper:24. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Avra Bhattacharjee)
If references are entirely missing, you can add them using this form.